Pharmarise 9-Mos Loss Y13.00M Vs Loss Y272.00M

Like
Comment
Favorite

Pharmarise 9-Mos Loss Y13.00M Vs Loss Y272.00M

Dow Jones03-19 16:00

    Pharmarise Holdings Corp. (2796.TO) 
    Japan 
    Nine Months Ended February 28 
GROUP              2026                    2025 
Revenue            Y50.56 bln        Y46.58 bln 
Operating Profit   Y603.00 mln       Y95.00 mln 
Pretax Profit      Y419.00 mln     (Y18.00 mln) 
Net Profit         (Y13.00 mln)   (Y272.00 mln) 
Per share 
  Earnings         (Y1.20)             (Y24.06) 
 
    Figures in parentheses are losses. 
 
    Results are based on Japanese accounting standards.

(END) Dow Jones Newswires

    Pharmarise Holdings Corp. also released the following forecasts: 
GROUP              Year Ending 
                      May 2026 
Revenue             Y66.80 bln 
Operating Profit     Y1.12 bln 
Pretax Profit      Y941.00 mln 
Net Profit         Y266.00 mln 
Per share 
  Earnings              Y23.45 
 
    Results are based on Japanese accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

March 19, 2026 04:00 ET (08:00 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2620217402?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 16:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620217402","market":"hk","top_or_hot":-1,"title":"Pharmarise 9-Mos Loss Y13.00M Vs Loss Y272.00M","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    Pharmarise Holdings Corp. (2796.TO) \n    Japan \n    Nine Months Ended February 28 \nGROUP              2026                    2025 \nRevenue            Y50.56 bln        Y46.58 bln \nOperating Profit   Y603.00 mln       Y95.00 mln \nPretax Profit      Y419.00 mln     (Y18.00 mln) \nNet Profit         (Y13.00 mln)   (Y272.00 mln) \nPer share \n  Earnings         (Y1.20)             (Y24.06) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    Pharmarise Holdings Corp. also released the following forecasts: \nGROUP              Year Ending \n                      May 2026 \nRevenue             Y66.80 bln \nOperating Profit     Y1.12 bln \nPretax Profit      Y941.00 mln \nNet Profit         Y266.00 mln \nPer share \n  Earnings              Y23.45 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 19, 2026 04:00 ET (08:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmarise 9-Mos Loss Y13.00M Vs Loss Y272.00M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmarise 9-Mos Loss Y13.00M Vs Loss Y272.00M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-19 16:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    Pharmarise Holdings Corp. (2796.TO) \n    Japan \n    Nine Months Ended February 28 \nGROUP              2026                    2025 \nRevenue            Y50.56 bln        Y46.58 bln \nOperating Profit   Y603.00 mln       Y95.00 mln \nPretax Profit      Y419.00 mln     (Y18.00 mln) \nNet Profit         (Y13.00 mln)   (Y272.00 mln) \nPer share \n  Earnings         (Y1.20)             (Y24.06) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 19, 2026 04:00 ET (08:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2620217402","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620217402","pubTimestamp":1773907200,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Pharmarise 9-Mos亏损Y13.00 M vs亏损Y272.00 M","themeId":"8603dabb40994e59ac78c04c930c0d49","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Pharmarise Holdings Corp. (2796.TO) \n    Japan \n    Nine Months Ended February 28 \nGROUP              2026                    2025 \nRevenue            Y50.56 bln        Y46.58 bln \nOperating Profit   Y603.00 mln       Y95.00 mln \nPretax Profit      Y419.00 mln     (Y18.00 mln) \nNet Profit         (Y13.00 mln)   (Y272.00 mln) \nPer share \n  Earnings         (Y1.20)             (Y24.06) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n\n\n  (END) Dow Jones Newswires\n\n\n\n    Pharmarise Holdings Corp. also released the following forecasts: \nGROUP              Year Ending \n                      May 2026 \nRevenue             Y66.80 bln \nOperating Profit     Y1.12 bln \nPretax Profit      Y941.00 mln \nNet Profit         Y266.00 mln \nPer share \n  Earnings              Y23.45 \n \n    Results are based on Japanese accounting standards. \n\n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 04:00 ET (08:00 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}